CoChat

Association of hypoglycemic symptoms with patients’ rating of their health-related quality of life state: A cross sectional study

Open access
Alvarez-Guisasola, Fernando, Yin, Donald D, Nocea, Gonzalo, Qiu, Ying, Mavros, Panagiotis · 2010 · Health and Quality of Life Outcomes

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Background: To evaluate the association between patient-reported hypoglycemic symptoms with ratings of their health-related quality of life state and patient-reported adverse events in patients with type 2 diabetes mellitus (T2DM). Methods: This observational, multicenter, cross sectional study was based on a sample of patients with T2DM from seven European countries who added sulfonylurea or thiazolidinedione to metformin monotherapy between January 2001 and January 2006. Included patients were required to have at least one hemoglobin A 1c (HbA 1c) measurement in the 12 months before enrollment and to not be receiving insulin. Demographic and clinical data from medical records were collected using case report forms. Questionnaires measured patient-reported hypoglycemic symptoms, health-related quality of life (EuroQol visual analogue scale, EQ-5D VAS), and treatment-related adverse events. Results: A total of 1,709 patients were included in the study. Mean patient age was 63 years, 45% were female, mean HbA 1c was 7.06%, and 28% were at HbA 1c goal (HbA 1c < 6.5%). Hypoglycemic symptoms during the 12 months before enrollment were reported by 38% of patients; among whom 68% reported their most severe symptoms were mild, 27% moderate, and 5% severe. Adjusted linear regression analyses revealed that patients reporting hypoglycemic symptoms had significantly lower EQ-5D VAS scores indicating worse patient-reported quality of life (mean difference -4.33, p < 0.0001). Relative to those not reporting symptoms, the adjusted decrement to quality of life increased with greater hypoglycemic symptom severity (mild: -2.68, p = 0.0039; moderate: -6.42, p < 0.0001; severe: -16.09, p < 0.0001). Patients with hypoglycemia reported significantly higher rates of shakiness, sweating, excessive fatigue, drowsiness, inability to concentrate, dizziness, hunger, asthenia, and headache (p < 0.0001 for each comparison). Conclusions: Hypoglycemic symptoms and symptom severity have an adverse effect on patients' rating of their health related quality of life state. Hypoglycemic symptoms are correlated with treatment-related adverse effects. Minimizing the risk and severity of hypoglycemia may improve patients' quality of life and clinical outcomes. Results are subject to limitations associated with observational studies including the potential biases due to unobserved patient heterogeneity and the use of a convenience sample of patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1477-7525-8-86

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Prevalence of patient-reported experience of hypoglycemic symptoms* and symptom severity† during the 12 months prior to the patient enrollment date. * Hypoglycemic symptoms are based on the response to the question: "Have you ever felt symptoms of hypoglycemia (low blood sugar) in the last year?". † Hypoglycemic symptom severity is based on the most severe form reported by a patient, i.e. if a patient reports both 'mild' and 'moderate' symptoms, the patient is listed only under the 'moderate' symptoms group. Mild symptoms were defined as: Little or no interruption of your activities, and you didn't feel you needed assistance to manage symptoms. Moderate symptoms were defined as: Some interruption of your activities, but you didn't feel you needed assistance to manage symptoms. The severe symptoms group is a consolidation of the 'severe' and 'very severe' symptoms that were respectively defined as: Felt that you needed assistance of others to manage symptoms (for example, to bring you food or drink), and needed medical attention (for example, called an ambulance, visited an emergency room or hospital, or saw a doctor or nurse).
Figure 1 Prevalence of patient-reported experience of hypoglycemic symptoms* and symptom severity† during the 12 months prior to the patient enrollment date. * Hypoglycemic symptoms are based on the response to the question: "Have you ever felt symptoms of hypoglycemia (low blood sugar) in the last year?". † Hypoglycemic symptom severity is based on the most severe form reported by a patient, i.e. if a patient reports both 'mild' and 'moderate' symptoms, the patient is listed only under the 'moderate' symptoms group. Mild symptoms were defined as: Little or no interruption of your activities, and you didn't feel you needed assistance to manage symptoms. Moderate symptoms were defined as: Some interruption of your activities, but you didn't feel you needed assistance to manage symptoms. The severe symptoms group is a consolidation of the 'severe' and 'very severe' symptoms that were respectively defined as: Felt that you needed assistance of others to manage symptoms (for example, to bring you food or drink), and needed medical attention (for example, called an ambulance, visited an emergency room or hospital, or saw a doctor or nurse).CC BY · PubMed Central
Figure 2 Patient-reported experience of treatment-related adverse events and experience of hypoglycemic symptoms. Points (filled boxes) signify odds ratios; error bars signify 95% confidence intervals.
Figure 2 Patient-reported experience of treatment-related adverse events and experience of hypoglycemic symptoms. Points (filled boxes) signify odds ratios; error bars signify 95% confidence intervals.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 78

Metadata

Authors
Alvarez-Guisasola, F., Yin, D. D., Nocea, G., Qiu, Y., & Mavros, P.
Affiliations
  • Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
  • MSD (Spain) (ES)
Corresponding author
Mavros, Panagiotis
Venue
Health and Quality of Life Outcomes
Published
2010-08-19
Volume
8
Issue
1
Pages
86-86
ISSN
1477-7525 (ISSN-L)
OpenAlex
W2147007805
Cited by
78
References
25
Citations by year
2026: 2 · 2024: 1 · 2023: 4 · 2021: 1 · 2020: 4 · 2019: 4 · 2018: 12 · 2017: 4 · 2016: 6 · 2015: 10 · 2014: 9 · 2013: 11 · 2012: 8
FWCI
4.82
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Health and Quality of Life Outcomes (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
hypoglycemia, hypoglycemic symptoms, health-related quality of life, type 2 diabetes, sulfonylureas, thiazolidinediones, metformin, treatment-related adverse events, symptom severity, patient-reported outcomes, EQ-5D, glycemic control, HbA1c, adverse drug reactions, patient satisfaction
MeSH terms
Activities of Daily Living, Aged, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Europe, Female, Health Status Indicators, Humans, Hypoglycemia, Life Style, Male, Middle Aged, Quality of Life, Surveys and Questionnaires, Linear Models, Sickness Impact Profile, Observation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association of hypoglycemic symptoms with patients’ rating of their health-related quality of life state: A cross sectional study. https://app.cochat.ai/papers/10.1186/1477-7525-8-86
The paper
Alvarez-Guisasola, F., Yin, D. D., Nocea, G., Qiu, Y., & Mavros, P. (2010). Association of hypoglycemic symptoms with patients’ rating of their health-related quality of life state: A cross sectional study. Health and Quality of Life Outcomes. https://doi.org/10.1186/1477-7525-8-86

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.